Clinical trial
Angiogenesis in Women With Angina Pectoris Who Are Not Candidates for…
NCT00438867 · Cardium Therapeutics, Industry · Unknown status
Key facts
| NCT number | NCT00438867 |
|---|---|
| Title | Angiogenesis in Women With Angina Pectoris Who Are Not Candidates for Revascularization |
| Official title | A Randomized, Double Blind, Placebo Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Ad5FGF-4 in Female Patients With Stable Angina Pectoris Who Are Not Candidates for Revascularization |
| Acronym | AWARE |
| Lead sponsor | Cardium Therapeutics, Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Angina Pectoris |
| Intervention type | Genetic |
| Interventions | Ad5FGF-4, Placebo |
| Enrollment | 300 |
| Start date | May 1, 2007 |
| Primary completion | Nov 1, 2009 |
| First posted | Feb 22, 2007 |
| Last update posted | Feb 13, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: